To CANCER IMMUNITY Home Page

Table 1

SSX mRNA expression in gynecological cancers.

 

Endometrial cancer

Ovarian cancer

Cervical cancer

SSX1

1/50 (2%)

0/40 (0%)

1/25 (4%)

SSX2

2/50 (4%)

1/40 (3%)

1/25 (4%)

SSX4

12/50 (24%)

5/40 (13%)

5/25 (20%)

 

Copyright © 2004 by Eiichi Nakayama